FierceBiotech 2026年6月4日 Autobahn races toward pivotal trial after thyroid hormone mimic eases bipolar depression in ph. 2
FierceBiotech 2026年6月4日 As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
FierceBiotech 2026年6月4日 From business strategy to CAR-T responses, for Cabaletta it’s all about ‘durability’
FierceBiotech 2026年6月4日 Alnylam pens $2B deal with Inceptive to transform siRNA design with AI pioneer
FierceBiotech 2026年6月3日 Lilly, Boehringer to slash at least $1B each from planned investments in Germany
FierceBiotech 2026年6月3日 As Akeso takes center stage at ASCO, China biotech industry cements its coming of age
FierceBiotech 2026年6月3日 Ascidian, Lilly ink RNA exon editing pact worth up to $1.9B for genetic kidney diseases
FierceBiotech 2026年6月2日 Foundation Medicine tallies FDA nod to pair its blood test with Pfizer’s prostate cancer combo
FierceBiotech 2026年6月2日 New heights for NewLimit as anti-aging biotech nabs $435M to rejuvenate old cells
FierceBiotech 2026年6月2日 ASCO: Roche, head held high, details oral SERD's first-line flop in breast cancer
FierceBiotech 2026年6月2日 Travere scales Everest with $1.1B deal for BTK inhibitor aimed at rare kidney diseases
FierceBiotech 2026年6月2日 Fulcrum scraps SCD program, considers options after FDA takes hard line on safety risks